Skip to main content
. 2016 Feb 18;27(6):1068–1074. doi: 10.1093/annonc/mdw073

Figure 3.

Figure 3.

(A) Reasons for nonenrollment on a clinical trial for patients with an eligible biomarker (N = 301). (B) Clinical trial enrollment stratified by the availability of remaining standard-of-care agent for all patients with a biomarker result (N = 458). (C) ATTACC-companion and non-ATTACC clinical trial enrolled patients stratified by the availability of remaining standard-of-care agent (N = 157). Error bars represent 95% confidence intervals.